argenx SE | Investor Presentation Deck | 22 slides · page 21 of 22
The chart uses a horizontal bar format to represent clinical trial stages (Preclinical to Commercial) for multiple indications under four main programs (VYVGART, Efgartigimod, ARGX-117, ARGX-119).
Conference presentation · roadmap · plan_implementation · sparse density
Slide locked Sign in to view
Slide schematic 3/3
legend 1/1 table 1/1 title 1/1
Components 3
legend data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1